InvestorsHub Logo
Followers 87
Posts 1780
Boards Moderated 0
Alias Born 03/13/2014

Re: fly_fisherman post# 13642

Thursday, 06/01/2017 11:25:09 AM

Thursday, June 01, 2017 11:25:09 AM

Post# of 33241
I disagree that there's no credibility with new clinicals. Sometimes you have to connect the dots on your own. There could easily be reasons on why they are being a little guarded with info.
They could have negotiated a tentative deal with a big Pharma company based on clinical heart results, with the stipulation that updates on the results are kept quiet in order to keep other companies off their heels to buyout. Never know.

But anyway, you don't just throw good money after bad with 8 currently running preclinicals. If they weren't getting good results and feedback from the early clinicals, there'd be a problem with the device that needs to hit the science lab again. You don't just keep running the same thing out there hoping it works on something else and paying hefty money to test it and find out.

So I DO think there's credibility in the fact that they are paying to continue the huge pipeline of testing different treatments at once.

And I think we are sticking a bunch of new ones into the pipeline, which means some are going to be coming out very very soon. Imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News